Unicorn Flexible Endoscopic Surgical Robot

The Unicorn (麒麟) Flexible Endoscopic Surgical Robot represents China’s first domestically developed flexible robotic platform for natural orifice transluminal endoscopic surgery in pulmonary applications. Developed by Longhe Medical and unveiled in 2021, this system integrates precision navigation, 360-degree flexible instrument control, and 5G remote operation capabilities for transbronchial procedures.

Product Overview

Unicorn addresses the clinical challenge of performing precise interventions on peripheral lung lesions through the natural airway. Traditional bronchoscopy provides limited reach and manipulation capability for peripheral nodules, while CT-guided percutaneous approaches carry risks of pneumothorax and bleeding. The Unicorn platform aims to combine the minimally invasive access of bronchoscopy with the precision and dexterity of robotic control.

The system emerged from Longhe Medical’s participation as lead organization in China’s National Key R&D Program for “Development of Transbronchial Diagnostic and Therapeutic Robot Systems” under the 14th Five-Year Plan. This government-backed initiative reflects strategic priority for developing domestic flexible surgical robot capabilities.

Key Features

Full Independent Intellectual Property: All core technologies and components have been developed domestically, providing full intellectual property ownership and enabling localized manufacturing. This foundation supports cost-effective deployment in Chinese healthcare settings.

360-Degree Flexible Control: The robotic arm design enables omnidirectional manipulation within the confined bronchial environment. This flexibility allows the system to navigate branching airway structures and position instruments at various angles relative to target lesions.

Ultra-Thin Endoscopy Integration: The platform incorporates miniaturized endoscopic imaging capable of visualizing peripheral bronchial anatomy and target lesions during procedures.

Real-Time Precision Navigation: Building on Longhe Medical’s navigation technology platform, the system provides continuous position tracking and pathway guidance throughout procedures.

Intelligent Visual Algorithms: AI-powered image processing assists with lesion identification, anatomical landmark recognition, and procedure guidance.

5G Remote Control Capability: The system architecture supports remote operation via 5G networks, potentially enabling expert physicians to guide procedures at distant facilities.

Technical Specifications

Unicorn’s 360-degree flexible bronchial articulation enables transbronchial access to peripheral lung lesions through electromagnetic and optical navigation with 5G remote control support.

Clinical Applications

Peripheral Lung Nodule Biopsy: The primary target application involves obtaining tissue samples from peripheral lung lesions that are difficult to reach with conventional bronchoscopy. Robotic control may improve sampling precision and yield compared to manual navigation.

Therapeutic Ablation: Beyond diagnosis, the platform can potentially deliver ablation energy (radiofrequency or microwave) to treat small peripheral lung tumors in patients who are not surgical candidates.

Marker Placement: The system can guide placement of fiducial markers for subsequent stereotactic radiation or surgical localization.

Regulatory Status

Unicorn is currently undergoing multicenter registration clinical trials in China, representing the first domestic clinical study for a pulmonary flexible surgical robot system. Regulatory approval timeline depends on clinical trial completion and data analysis.

Development Background

The flexible surgical robot market for pulmonary applications has been pioneered by international competitors including Auris Health (now part of Johnson & Johnson) with the Monarch platform and Intuitive Surgical with the Ion system. Both systems have demonstrated commercial success in the United States.

Longhe Medical developed Unicorn to provide comparable technological capability with domestic intellectual property, localized manufacturing, and pricing appropriate for the Chinese healthcare system. The company’s 2021 unveiling of Unicorn positioned China as the second country after the United States to systematically master natural orifice flexible surgical robot technology for pulmonary applications.

Competitive Differentiation

Compared to international flexible bronchoscopy robots, Unicorn emphasizes several differentiating factors:

• Complete domestic intellectual property enabling technology independence
• Localized core component manufacturing for cost optimization
• 5G remote operation architecture for telemedicine applications
• Integration with Longhe Medical’s existing navigation platform

Frequently Asked Questions

When will Unicorn receive NMPA approval?

Unicorn is currently in multicenter registration clinical trials. Approval timing depends on trial completion, data analysis, and regulatory review. Longhe Medical has not announced a specific expected approval date.

How does Unicorn compare to the Monarch and Ion systems?

Unicorn targets similar clinical applications as Auris Health’s Monarch and Intuitive Surgical’s Ion platforms. All three systems enable robotic-assisted navigation and intervention for peripheral lung lesions. Unicorn differentiates through domestic IP ownership, localized manufacturing, 5G remote capability, and potentially lower acquisition cost for Chinese hospitals.

What procedures can Unicorn perform?

Unicorn is designed for transbronchial diagnostic procedures (biopsy, brushing, lavage) and therapeutic interventions (ablation, marker placement) on peripheral lung lesions. The specific approved indications will depend on clinical trial outcomes and regulatory decisions.

Does Unicorn require a dedicated operating room?

Specific facility requirements will be finalized with regulatory approval. The system is designed to work within existing bronchoscopy suite environments, potentially requiring less dedicated space than larger laparoscopic surgical robots.